期刊
MOLECULAR IMMUNOLOGY
卷 150, 期 -, 页码 90-98出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2022.08.002
关键词
Complement; Paul Ehrlich; Nobel Prize; Innate Immunity; Hemolysis; Bacteriolysis; Microbial Lysis
资金
- Collaborative Research Center, FungiNet
- DFG Immune Mediated Kidney Disease [SDB1192]
- Deutsche Forschungsgemeinschaft (DFG)
- KID-NEEDS Foundation Iowa City USA
Paul Ehrlich, a pioneering immunobiologist and physician, coined the term 'complement' and made substantial contributions to immunobiology and medicine. His work on immunity led to the identification of complement and he was awarded the Nobel Prize in 1908. He also played a role in the diagnosis and treatment of complement-mediated diseases.
Paul Ehrlich was a pioneering Immunobiologist and physician who coined the term 'complement' in the year 1899. He was a leading visionary scientist who worked in the late 19th and early 20th centuries in Berlin and Frankfurt. He received numerous awards and honors for his substantial contributions to immunobiology and medicine, including the identification of complement, and he received the Nobel Prize in Physiology or Medicine in 1908 in recognition of his work on immunity.During his clinical work, Paul Ehrlich treated a patient with paroxysmal hemoglobinuria and reported his diagnostic approaches, including those related to erythrocyte lysis and microscopic cell analysis, to the Verein fur Innere Medicine/Society of Internal Medicine, Berlin. Paroxysmal nocturnal hemoglobinuria was shown to be a complement-mediated disease; treatment of this disease with the complement inhibitor Eculzimab/Soliris was approved by the European Medicines Agency in 2003 and by the United States Food and Drug Administration in 2007.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据